Showing 1 - 16 results of 16 for search 'Eduardo Rodríguez-Arbolí', query time: 0.24s Refine Results
  1. 1
    Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Incidence and risk factors for hypertension among HIV patients in rural Tanzania - A prospective cohort study.
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Long-Term Impact of an Educational Antimicrobial Stewardship Program on Management of Patients with Hematological Diseases
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET<sup>®</sup> CC-96191
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Validation of mutated <i>CEBPA</i> bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory <i>FLT3</i>-ITD Mutation-Positive Acute Myeloid Leukemia
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    PB1779: FLT3-ITD MUTATION CHARACTERIZATION WITH CLASSICAL PCR METHODOLOGY VERSUS CAPTURE- AND AMPLICON-BASED NGS PLATFORMS: A PETHEMA NGS-AML PROJECT
    Get full text
    Article
    Save to List
    Saved in:
Search Tools: RSS Feed – Email Search